Skip to main content

Table 3 HRs and 95% CIs of outcomes according to the categories of plasma sST2 in Model 2

From: Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus

Outcomes sST2 level
 < 19 ng/ml  ≥ 19 ng/ml P trend
Primary outcome: MACEs 775
 Number of cases (%) 321 (17.66) 454 (24.90)  < 0.001
 Model 2 HR 1.00 (REF) 1.36 (1.17–1.56)  < 0.001
 Cardiac death 163
 Number of cases (%) 48 (2.64) 115 (6.31)  < 0.001
 Model 2 HR 1.00 (REF) 1.70 (1.50–1.98) 0.033
 MI 57
 Number of cases (%) 21 (1.1) 36 (1.8) 0.066
 Model 2 HR REF 1.17 (0.67–2.04) 0.579
 Unstable angina 550
 Number of cases (%) 245 (13.48) 305 (16.73) 0.280
 Model 2 HR REF 1.42 (1.25–1.98)  < 0.001
 Revascularization treatment 5
 Number of cases (%) 2 (0.11) 3 (0.16) 0.343
Model 2 HR REF 1.08 (0.94–1.17) 0.265
Secondary outcome: all-cause death 275
Number of cases (%) 90 (4.95) 185 (10.15)  < 0.001
Model 2 HR 1.00 (REF) 2.01 (1.56–2.59)  < 0.001